Randomized Trialhigh evidence
Epigenetic aging during adjuvant chemotherapy for colon cancer and modification by a resistance training intervention.
Journal of the National Cancer Institute·August 3, 2026·PMID 42544784
Why it mattersAdjuvant chemotherapy may accelerate biological aging in colon cancer patients, contributing to long-term functional decline. This study provides the first evidence that a resistance training intervention can mitigate chemotherapy-associated epigenetic aging, suggesting a potential strategy to preserve long-term health in cancer survivors.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled